About 1 in 3 adults in the United States have prediabetes, a condition where blood glucose levels are higher than normal, but ...
The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...
Axios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...
Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Discover the soothing process of making diabetes-friendly green rice porridge, designed to nourish and satisfy. Watch as each ingredient is carefully prepared and cooked to perfection, creating a ...
Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...
The surgeon general’s report said the lifetime risk of developing any alcohol-related cancer jumped to 19 percent (19 of 100 ...
The highly decorated Special Forces soldier who died by suicide in a Cybertruck explosion on New Years Day confided to a ...
GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...
The 119th Congress will begin Friday and already there’s talk of gridlock. Speaker Mike Johnson wants to remain the speaker but may not have enough votes to hold onto the gavel.